The European Commission has selected eight large-scale research projects through the Innovative Medicines Initiative (IMI) launched in March. IMI is a public-private partnership. The projects all revolve around developing treatments and diagnostics for the coronavirus and were fast-tracked due to the pandemic.
Five of the projects focus on diagnostics and three focus on treatments. The former will work on devices that can be used anywhere, from the doctor's surgery to a patient's home with fast results. The treatment projects will make focus on the current outbreak but will also prepare for future outbreaks.
The Commission upped its committment from €45 million to €72 million in order to fund a larger number of the high-quality proposals received.
The list of selected projects can be found here and more information about the announcement is available here.